当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析 - 现金流量表

健帆生物

(300529)

  

流通市值:98.55亿  总市值:153.57亿
流通股本:5.12亿   总股本:7.99亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金612,829,952.252,337,937,853.611,768,386,740.741,299,776,192.19
  收到的税费返还-1,124,050.98946,942.18797,579.13
  收到其他与经营活动有关的现金2,057,769.4120,926,644.4296,557,078.25102,177,855.8
  经营活动现金流入小计614,887,721.652,459,988,549.011,865,890,761.171,402,751,627.12
  购买商品、接受劳务支付的现金100,288,085.89392,690,993.02305,564,662.82188,856,764.35
  支付给职工以及为职工支付的现金113,006,004.39529,150,844.65407,206,778.95290,208,099.41
  支付的各项税费94,818,308.66401,746,893.77314,020,246.06214,627,171.36
  支付其他与经营活动有关的现金50,883,913.85415,183,374.38265,858,918.17170,778,156.61
  经营活动现金流出小计358,996,312.791,738,772,105.821,292,650,606864,470,191.73
  经营活动产生的现金流量净额255,891,408.86721,216,443.19573,240,155.17538,281,435.39
二、投资活动产生的现金流量:
  收回投资收到的现金1,027,314,9794,534,406,869.911,919,605,241.541,778,730,364.61
  取得投资收益收到的现金125,742.0953,475,879.18,757,199.68,378,243.26
  处置固定资产、无形资产和其他长期资产收回的现金净额10,6292,861,393.122,440,528.291,665,940.29
  投资活动现金流入小计1,027,451,350.094,590,744,142.131,930,802,969.431,788,774,548.16
  购建固定资产、无形资产和其他长期资产支付的现金42,545,502.81172,590,825.89118,273,187.5988,819,929.41
  投资支付的现金3,181,479,265.513,775,000,0003,054,950,0002,589,950,000
  投资活动现金流出小计3,224,024,768.323,947,590,825.893,173,223,187.592,678,769,929.41
  投资活动产生的现金流量净额-2,196,573,418.23643,153,316.24-1,242,420,218.16-889,995,381.25
三、筹资活动产生的现金流量:
  取得借款收到的现金30,481,906.94100,274,614.5778,265,413.3145,151,704.66
  收到其他与筹资活动有关的现金626,052.921,133,104,213.27449,965,192.8928,796,931.82
  筹资活动现金流入小计31,107,959.861,233,378,827.84528,230,606.273,948,636.48
  偿还债务支付的现金2,244,093.2263,431,621.0232,120,327.4432,110,857.44
  分配股利、利润或偿付利息支付的现金1,057,149.42643,568,950.08640,672,599.99639,269,472.46
  支付其他与筹资活动有关的现金111,384,487.35889,710,113.08451,907,353.5130,041,154.44
  筹资活动现金流出小计114,685,729.971,796,710,684.181,124,700,280.94701,421,484.34
  筹资活动产生的现金流量净额-83,577,770.11-563,331,856.34-596,469,674.74-627,472,847.86
四、汇率变动对现金及现金等价物的影响-1,821,163.03-1,722,510.72-525,067.8593,947.11
五、现金及现金等价物净增加额-2,026,080,942.51799,315,392.37-1,266,174,805.58-979,092,846.61
  加:期初现金及现金等价物余额2,474,981,633.621,675,666,241.251,675,666,241.251,675,666,241.25
  期末现金及现金等价物余额448,900,691.112,474,981,633.62409,491,435.67696,573,394.64
补充资料:
  净利润-531,671,178.89-388,668,556.92
  资产减值准备-63,877,891.55-3,760,902.26
  固定资产和投资性房地产折旧-115,092,151.34-58,730,030.61
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-115,092,151.34-58,730,030.61
  无形资产摊销-4,905,371.08-2,156,071.63
  长期待摊费用摊销-13,748,538.86-8,569,780.78
  处置固定资产、无形资产和其他长期资产的损失-79,851.27-1,413,498.67
  固定资产报废损失-1,608,135.5-682,958.8
  公允价值变动损失--11,065.14--21,552,025.71
  财务费用-53,511,826.05-26,807,559.18
  投资损失--53,475,879.1--8,330,958.77
  递延所得税--7,052,083.45--16,190,686.97
  其中:递延所得税资产减少--6,395,597.31--19,190,904.39
    递延所得税负债增加--656,486.14-3,000,217.42
  存货的减少-38,617,748.4-3,277,523.29
  经营性应收项目的减少-10,648,124.21-5,518,555.37
  经营性应付项目的增加--58,155,971.54-65,044,209.58
  其他-3,644,497-18,574,999.98
  不涉及现金收支的投资和筹资活动金额其他项目-1,416,074.18--
  现金的期末余额-2,474,981,633.62-696,573,394.64
  减:现金的期初余额-1,675,666,241.25-1,675,666,241.25
  现金及现金等价物的净增加额-799,315,392.37--979,092,846.61
公告日期2026-04-282026-04-282025-10-302025-08-22
审计意见(境内)标准无保留意见
TOP↑